Development of S-adenosyl-L-methionine (SAM)-reinforced probiotic yogurt using Bifidobacterium bifidum BGN4

Food Science and Biotechnology

Volumn 17, Issue 5, 2008, Pages 1025-1031

  Kim, Ji Youn ^a   Seo, Han K ^a   Min, Jeong Seo ^a   Suh, Joo Won ^b   Hwang, Inkyeong ^a   Ji, Geun Eog ^a,c  

^a Seoul National University   (South Korea)

^b Myong Ji University   (South Korea)

^c Bifido Co   (South Korea)

Author keywords

Bifidobactrium bifidum BGN4; Response surface methodology (RSM); S adenosyl L methionine; Sensory acceptance; Yogurt

Indexed keywords

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM;

EID: 56249138313     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gorman JM. Gender differences in depression and response to psychotropic medication. Gend. Med. 3: 93-109 (2006)
2. WHO. Part 1. Ten Statistical Highlights in Global Public Health. World Health Statistics 2007. World Health Organization, Geneva, Switzerland. p.16 (2007)
3. Cassano P, Fava M. Depression and public health: An overview. J. Psychosom. Res. 53: 849-857 (2002)
4. Bottiglieri T, Hyland K. S-Adenosylmethionine levels in psychiatric and neurological disorders: A review. Acta Neurol. Scand. (Suppl.) 154: 19-26 (1994)
5. Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademethionine (S-adenosylmethionine) in neurological disorders. Drugs 48: 137-152 (1994)
6. Fetrow CW, Avila JR. Efficacy of the dietary supplement S-adenosyl-L-methionine. Ann. Pharmacother. 35: 1414-1425 (2001)
7. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: A review of the evidence. Am. J. Clin. Nutr. 76: 1158-1161 (2002)
8. Williams AL, Girard C, Jui D, Sabina A, Katz DL. S-Adenosylmethionine (SAMe) as treatment for depression: A systematic review. Clin. Invest. Med. 28: 132-139 (2005)
9. Lu SC, Mato JM. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol 35: 227-234 (2005)
10. Mato JM, Lu SC. Role of S-adenosyl-L-methionine in liver health and injury. Hepatology 45: 1306-1312 (2007)
11. Bradley JD, Flusser D, Katz BP, Schumacher HR Jr, Brandt KD, Chambers MA, Zonay LJ. A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis. J. Rheumatol. 21: 905-911 (1994)
12. Morelli V, Naguin C, Weaver V. Alternative therapies for traditional disease states: Osteoarthritis. Am. Fam. Physician 67: 339-344 (2003)
13. Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: Effects of treatment with parenteral and oral S-adenosylmethionine. J. Neurol. Neurosurg. Ps. 53: 1096-1098 (1990)
14. Morrison LD, Smith DD, Kish SJ. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J. Neurochem. 67: 1328-1331 (1996)
15. Kim JY, Suh JW, Ji GE. Evaluation of S-adenosyl-L- methionine production by Bifidobacterium bifidum BGN4. Food Sci. Biotechnol. 17: 184-187 (2008)
16. Kim H, Kwack K, Kim DY, Ji GE. Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model. FEMS Immunol. Med. Mic. 45: 259-267 (2005)
17. Kim H, Lee SY, Ji GE. Timing of Bifidobacterium administration influences the development of allergy to ovalbumin in mice. Biotechnol. Lett. 27: 1361-1367 (2005)
18. high T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation. Clin. Immunol. 123: 30-39 (2007)
19. Logan AC, Katzman M. Major depressive disorder: Probiotics may be an adjuvant therapy. Med. Hypotheses 64: 533-538 (2005)
20. You HJ, Oh DK, Ji GE. Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4. FEMS Microbiol. Lett. 240: 131-136 (2004)
21. Karnovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J. Cell Biol. 27: 137A-138A (1965)
22. Kim KH, Shin WC, Park YS, Yoon SS. In situ detection and differential counts of Bifidobacterium spp. using bromocresol green, a pH-dependent indicator. Food Sci. Biotechnol. 16: 99-103 (2007)
23. Shaker RR, Jumah RY, Abu-Jdayil B. Rheological properties of plain yogurt during coagulation process: Impact of fat content and preheat treatment of milk. J. Food Eng. 44: 175-180 (2000)
24. Yazici F, Akgun A. Effect of some protein based fat replacers on physical, chemical, textural, and sensory properties of strained yoghurt. J. Food Eng. 62: 245-254 (2004)
25. Saint-Eve A, Martin N, Levy C, Souchon I. How can protein ratio affect aroma release, physical properties, and perceptions of yoghurt? Dev. Food Sci. 43: 391-394 (2006)
26. Mohameed HA, Abu-Jdayil B, Al-Shawabkeh A. Effect of solids concentration on the rheology of labneh (concentrated yogurt) produced from sheep milk. J. Food Eng. 61: 347-352 (2004)
27. Haque A, Richardson RK, Morris ER. Effect of fermentation temperature on the rheology of set and stirred yogurt. Food Hydrocolloid 15: 593-602 (2001)
28. Sodini I, Remeuf F, Haddad S, Corrieu G. The relative effect of milk base, starter, and process on yogurt texture: A review. Crit. Rev. Food Sci. 44: 113-137 (2004)
29. Akin MB, Akin MS, Kirmaci Z. Effects of inulin and sugar levels on the viability of yogurt and probiotic bacteria and the physical and sensory characteristics in probiotic ice-cream. Food Chem. 104: 93-99 (2007)
30. Afonso IM, Maia JM. Rheological monitoring of structure evolution and development in stirred yoghurt. J. Food Eng. 42: 183-190 (1999)
31. Kälviäinen N, Roininen K, Tuorila H. The relative importance of texture, taste, and aroma on a yogurt-type snack food preference in the young and the elderly. Food Qual. Prefer. 14: 177-186 (2003)